183388-64-9

Basic information

• Product Name: (2S,3S,5S)-5-tert-Butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexane succinate
• Synonyms: (2S,3S,5S)-5-tert-Butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexne 1/2 succinate (BDH Succinate salt);(2S,3S,5S)-2-Amino-3-hydroxy-5-(tert-butyloxy carbonyl)amino-1,6-diphenylhexane succinate;(2S,3S,5S)-2-aMino-3-hydroxy-5-(tert-butyloxycarbonyl)aMino-1,6-diphenyl heMi succinic acid salt (BDH succinic acid salt);(2S,3S,5S)-2-aMino-3-hydroxy-5-(t-butyloxycarbonylaMino)-1,6-diphenylhexane heMi succinic acid salt;(2s,3s,5s)-5-tert-butyloxycarbonylaMino-2-aMino-3-hydroxy-1,6-diphenylhexane succinate(BDH Succinate Salt);BDH SUCCINIC ACID SALT;bdh succinate salt;(2s,3s,5s)-5-tert-butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexane succinate
• CAS NO: 183388-64-9
• Molecular Formula: 2C23H32N2O3.C4H6O4
• Molecular Weight: 887.12
• Mol File: 183388-64-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 569.2ºC at 760 mmHg
• Flash Point: 298ºC
• Appearance: /
• Vapor Pressure: 8.56E-14mmHg at 25°C
• CAS DataBase Reference: (2S,3S,5S)-5-tert-Butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexane succinate(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3S,5S)-5-tert-Butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexane succinate(183388-64-9)
• EPA Substance Registry System: (2S,3S,5S)-5-tert-Butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexane succinate(183388-64-9)

Safety Data

• Hazardous Substances Data: 183388-64-9(Hazardous Substances Data)

Usage

General Description

(2S,3S,5S)-5-tert-Butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexane succinate is a chemical compound with a complex structure. It consists of a succinate group coupled with a 1,6-diphenylhexane structure, containing an amino and hydroxy group. Additionally, it has a tert-butyloxycarbonylamino group attached to the 5th carbon, making it a derivative of the amino acid, valine. (2S,3S,5S)-5-tert-Butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexane succinate may have potential applications in the pharmaceutical industry, particularly in drug development, due to its unique structure and potential biological activity. Further research and study are necessary to fully understand the properties and potential uses of this compound.

InChI:InChI=1/C23H32N2O3.C4H6O4/c1-23(2,3)28-22(27)25-19(14-17-10-6-4-7-11-17)16-21(26)20(24)15-18-12-8-5-9-13-18;5-3(6)1-2-4(7)8/h4-13,19-21,26H,14-16,24H2,1-3H3,(H,25,27);1-2H2,(H,5,6)(H,7,8)/t19-,20-,21-;/m0./s1

Upstream product

• 110-15-6 succinic acid 
• 144163-85-9 (2S,3S,5S)-2-amino-3-hydroxy-5-(t-butyloxycarbonylamino)-1,6-diphenylhexane 
• 63-91-2 L-phenylalanine 

Downstream Products

• 192725-45-4 (2S,3S,5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(t-butyloxycarbonylamino)-1,6-diphenylhexane 

Relevant articles and documents

Diastereoselective synthesis of a core fragment of ritonavir and lopinavir

A novel approach to the synthesis of Boc-core, a key starting material for ritonavir and lopinavir involving an unprecedented diastereoselective nitroaldol reaction on β-amino aldehyde is disclosed.

HIV protease inhibiting compounds

A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.

RETROVIRAL PROTEASE INHIBITING COMPOUNDS

A compound of the formula: STR1 is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.